| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| rhenium[186Re] 37-370 MBq/ml kolloidt injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| Rhenium (186-Re) etidronate (substance) |
Is a |
False |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| Rhenium (186-Re) hydroxyethylidene diphosphonate (substance) |
Is a |
False |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| Product containing rhenium-186 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| rhenium[186Re]-hydroxyethyliden-diphosphonat 1295 MBq injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| rhenium[186Re]-etidronat 1,3 GBq/ml pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| SPECT of bone of ankle using 186-Re (rhenium-186) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| SPECT of bone of knee using 186-Re (rhenium-186) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| Single photon emission computed tomography of bone of elbow using rhenium-186 (procedure) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| SPECT CT of bone of elbow using 186-Re (rhenium-186) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| Single photon emission computed tomography with computed tomography of bone of knee using rhenium-186 (procedure) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
2 |
| SPECT CT of bone of ankle using 186-Re (rhenium-186) |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
2 |
| Radionuclide imaging of whole body for detection of extra-articular leakage of rhenium-186 |
Using substance (attribute) |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
| Rhenium (186-Re) etidronate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| Rhenium (186-Re) hydroxyethylidene diphosphonate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
|
| Rhenium-186 only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rhenium-186 (substance) |
Inferred relationship |
Some |
1 |
FHIR